Literature DB >> 26683837

Mutation Scanning of D1705 and D1709 in the RNAse IIIb Domain of MicroRNA Processing Enzyme Dicer in Cutaneous Melanoma.

Michael Sand1,2, Falk G Bechara3, Marina Skrygan3, Daniel Sand4, Thilo Gambichler3, Michael Bromba5, Eggert Stockfleth3, Schapoor Hessam3.   

Abstract

Since the discovery of microRNAs (miRNAs) there have been performed several studies showing perturbations in the expression of miRNAs and the miRNA expression machinery in cutaneous melanoma. Dicer, a pivotal cytosolic enzyme of miRNA maturation has shown to be affected by both somatic and germline mutations in a variety of cancers. Recent studies have shown that recurrent somatic mutations of Dicer frequently affect the metal-ion-binding sites D1709 and D1705 of its RNase IIIb domain, therefore called hot spot mutations. The present study investigates metal-ion-binding sites D1709 and D1705 of the Dicer RNase IIIb domain in cutaneous melanomas and melanoma metastasis by Sanger sequencing. All investigated samples showed wildtype sequence and no single mutation was detected. The miRNA processing enzyme Dicer of melanoma and melanoma metastasis does not appear to be affected by mutation in the metal-ion-binding sites D1709 and D1705 of its RNase IIIb domain.

Entities:  

Keywords:  Dicer; Melanoma; MicroRNA; Mutation

Mesh:

Substances:

Year:  2015        PMID: 26683837     DOI: 10.1007/s12253-015-0034-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  9 in total

1.  microRNAs exhibit high frequency genomic alterations in human cancer.

Authors:  Lin Zhang; Jia Huang; Nuo Yang; Joel Greshock; Molly S Megraw; Antonis Giannakakis; Shun Liang; Tara L Naylor; Andrea Barchetti; Michelle R Ward; George Yao; Angelica Medina; Ann O'brien-Jenkins; Dionyssios Katsaros; Artemis Hatzigeorgiou; Phyllis A Gimotty; Barbara L Weber; George Coukos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 2.  The pathway of miRNA maturation.

Authors:  Michael Sand
Journal:  Methods Mol Biol       Date:  2014

Review 3.  MicroRNAs in melanocyte and melanoma biology.

Authors:  Marina Mione; Anja Bosserhoff
Journal:  Pigment Cell Melanoma Res       Date:  2015-01-06       Impact factor: 4.693

4.  Nucleotide sequence of bacteriophage lambda DNA.

Authors:  F Sanger; A R Coulson; G F Hong; D F Hill; G B Petersen
Journal:  J Mol Biol       Date:  1982-12-25       Impact factor: 5.469

5.  Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.

Authors:  Michael Sand; Thilo Gambichler; Daniel Sand; Peter Altmeyer; Markus Stuecker; Falk G Bechara
Journal:  Eur J Dermatol       Date:  2011 Jan-Feb       Impact factor: 3.328

Review 6.  DICER1: mutations, microRNAs and mechanisms.

Authors:  William D Foulkes; John R Priest; Thomas F Duchaine
Journal:  Nat Rev Cancer       Date:  2014-09-01       Impact factor: 60.716

7.  MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.

Authors:  Yael Nemlich; Eyal Greenberg; Rona Ortenberg; Michal J Besser; Iris Barshack; Jasmine Jacob-Hirsch; Elad Jacoby; Eran Eyal; Ludmila Rivkin; Victor G Prieto; Nitin Chakravarti; Lyn M Duncan; David M Kallenberg; Eitan Galun; Dorothy C Bennett; Ninette Amariglio; Menashe Bar-Eli; Jacob Schachter; Gideon Rechavi; Gal Markel
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

8.  Molecular and genetic diversity in the metastatic process of melanoma.

Authors:  Katja Harbst; Martin Lauss; Helena Cirenajwis; Christof Winter; Jillian Howlin; Therese Törngren; Anders Kvist; Björn Nodin; Eleonor Olsson; Jari Häkkinen; Karin Jirström; Johan Staaf; Lotta Lundgren; Håkan Olsson; Christian Ingvar; Sofia K Gruvberger-Saal; Lao H Saal; Göran Jönsson
Journal:  J Pathol       Date:  2014-01-27       Impact factor: 7.996

9.  Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers.

Authors:  Loredana Pellegrino; Jimmy Jacob; Laura Roca-Alonso; Jonathan Krell; Leandro Castellano; Adam E Frampton
Journal:  Expert Rev Anticancer Ther       Date:  2013-01       Impact factor: 4.512

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.